参考文献

出处：按学科分类—医药、卫生 上海科学技术文献出版社《临床心律失常诊疗手册》第126页（5159字）

［1］王鸣和，余长葆．冠状动脉闭塞性心律失常．心血管病学进展，1991，12(2)：89～93

［2］王鸣和．冠心病患者再灌注性心律失常．国外医学心血管疾病分册，1986，13(4)：200～203

［3］卞士平，吴华．间歇性预激综合征心电图特点及机制探讨．临床心电学杂志，2002，11：27

［4］时向民，王玉堂．房室旁路(Mahaim纤维)心动过速的诊断与治疗．医师进修杂志，2001，24：2

［5］胡大一，马长生．显性旁道体表心电图定位．见：胡大一，马长生主编．心律失常射频消融图谱(第2版)．北京：人民卫生出版社，2002，1～3

［6］夏宏器．室性期前收缩的临床意义、治疗及预后．国际心血管杂志，2003，5(3)：239～242

［7］曾群英．预激综合征的诊断和治疗．新医学，2002，33：141

［8］Al Khatib SM，Pritchett EL．Clinical features of Wolff-Parkinson-White syndrome．Am Heart J，1999，138：403

［9］Buxton AE，Lee KL，Dicarlo L et al．for the Multicenter Unsustained Tachycardia Trial Investigators (MUSTT)：Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death ．N Engl J Med，2000，342：1937

［10］Englund A，Behrens S，Wegscheider K，et al．Circadian variation of malignant ventricular arrhythmias in patients with ischemic and nonischemic heart disease after cardioverter defibrillators implantation．European 7219 Jewel Investigators．J Am Coll Cardiol，1999，34：1560～1568

［11］Folk Rh，DeCara JM．Dofetilide：A new pure class Ⅲ antiarrhythmic agent．Am Heart J，2000，140：697

［12］Fuster V，Ryden LE，Asinger Rw，et al．ACC/AHA，ESC guidelines for the management of patients with atrial fibrillation：A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference (Committee to Develop Guidelines for the Management of patients with Atrial Fibrillation)．J Am Coll Cardiol，2001，38：1266i

［13］Fries R，Hein S，Konig K．Reversed circadian rhythms of heart rate variability and morning peak occurrence of sustained ventricular tachyarrhythmias in patients with implanted cardioverter defibrillator．Med Sci Monit，2002，8：CR751～756

［14］Gollob MJI，Green MG，Tang AS-L，et al．Identification of a gene responsible for familial Wolff Parkinson White syndrome．N Engl Med，2001，344：1823

［15］Hohnloser SH，Kuck KH，Lilienthal J．Rhythm or rate control in atrial fibrillation：Pharmacological interention in Atrial Fibrillation (PIAF)：A randomised trial．Lancet，2000，356：1789

［16］Kurnik PB．Circadian in the efficacy of tissue-type plasminogen ctivator．Circulation，1995，91：1341～1346

［17］Lampert R，Rosenfeld L，Batsford W，et al．Circardian variation of sustained ventricular tachycardia in patients with coronary artery disease and implantable cardioverter defibrillators．Circulation，1994，90：241～247

［18］MacRae CA，Ghaisas N，Kass S，et al．Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7 q 3．J Clin Invest，1995，96：1216

［19］Mulcahy D，Keegan J，Cunningham D，et al．Circadian variation of total ischaemic burden and its alteration with antianginal agents．Lancet，1988，2：755～799

［20］Maarouf N，Rowland E．What makes patients vulnerable to ventricular tachycardia or fibrillation? Eur Heart J，2003，5(S1)：122～127

［21］Peters RW，McQuillan S，Resnick SK，et al．Increased Monday incidence of life threatening ventricular arrhythmias．Experience with a third-generation implantable defibrillator．Circulation，1996，94：1346～1349

［22］Poloniecki JD，Atkinson RW，de Leon AP，et al．Daily time series for cardiovascular hospital admissions and previous day’s air pollution in London，UK．Occup Environ Med，1997，54：535～540

［23］Peters A，Liu E，Verrier RL，et al．Air pollution and incidence of cardiac arrhythmia．Epidemiology，2000，11：11～17

［24］Schmitt H，Weber S，Tilmanns H，et al．Diagnosis and ablation of atrial flutter using a high resolution，noncontact mapping system．PACE，2000，23：2057

［25］Schmitt H，Weber S，Schwab JO，et al．Diagnosis and ablation of focal night atrial tachycardia using a new high-resolution，non-contact mapping system．Am J Cardiol，2001，87：1017～1021

［26］Tamimi H，Mansour M，Pepine CJ，et al．Circadian variation in coronary tone in patients with stable angina．Protective role of the endothelium．Circulation，1995，92：3201～3205

［27］Taneda K，Aizawa Y．Absence of a morning peak in ventricular tachycardia and fibrillation events in nonischemic heart disease：analysis of therapies by implantable cardioverter defibrillators．Pacing Clin Electrophysiol，2001，24：1602～1606

［28］Ueng KC，Lee SH，Wu DJ，et al．Radiofrequency catheter modification of atrioventricular junction in patients with COPD and medically refractory multifocal atrial tachycardia．chest 2000;117：52

［29］Wood MA，Brown-Mavoney C，Kay GN，et al．Clinical outcomes after ablation and pacing therapy for atrial fibrillation：A meta-analysis Circulation，2000，101：1138